Hap Trading, LLC Pharma Cyte Biotech, Inc. Call Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$1.99 - $2.33 $1,592 - $1,864	800 Added 5.48%	15,400 $4,000
Q1 2022 May 12, 2022	SELL	$1.91 - $2.77 $12,988 - $18,836	-6,800 Reduced 31.78%	14,600 $3,000
Q4 2021 Feb 14, 2022	BUY	$2.4 - $3.19 $51,360 - $68,266	21,400 New	21,400 $6,000

932K

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $35.5M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.